Zobrazeno 1 - 10
of 10
pro vyhledávání: '"YI-XIANG MAO"'
Autor:
Long‑Pei Chen, Dao‑Ming Li, Meng‑Yao Wu, Kai Chen, Wei Li, Fei‑Ran Gong, Yufeng Xie, Liu‑Mei Shou, Min Tao, Yi‑Xiang Mao, Wei‑Ming Duan, Xin Xie
Publikováno v:
Oncology Letters
Cantharidin is an active constituent of mylabris, a traditional Chinese therapeutic agent. Cantharidin is a potent and selective inhibitor of protein phosphatase 2A (PP2A). Cantharidin has been previously reported to efficiently repress the growth of
Autor:
Hai-Yan Dai, Yongqiang Hua, Lanyun Feng, Luming Liu, Yi-Xiang Mao, Xiaoyan Zhu, Kun Wang, Zhen Chen, Lianyu Chen, Zhiqiang Meng, Peng Wang
Publikováno v:
Integrative Cancer Therapies. 9:291-297
Background: Traditional Chinese medicine (TCM) syndromes ( ZHENG in Chinese) are the abstraction from the comprehensive analysis of clinical information gained by the four main diagnostic TCM methods: observation, listening, questioning, and pulse an
Autor:
Yi-xiang Mao, Yan Ge, Qin Shi, Hong-ya Wu, Xueguang Zhang, Jian-feng Yu, Qin Wang, Yong-jing Chen, Hong-bing Ma, Yumin Hu
Publikováno v:
Acta Pharmacologica Sinica. 27:741-746
Aim: To explore the biofunctions of human B7-H4 generated from prokaryotic system. Methods: The gene of human B7-H4 extracellular region (IgV-like and IgC-like domains) was obtained by PCR from human cDNA FLJ22418 and then inserted into the prokaryot
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 27(4)
Cancer patients have a poor immune response and chemotherapy could deteriorate their immune system further. Reasonable immune therapy is an important adjuvant remedy for tumors. This study was to monitor the changes of T-cell phenotypes in peripheral
[Preparation and characterization of two novel functional monoclonal antibodies against human OX40L]
Autor:
Hong-ya, Wu, Qin, Wang, Yong-jing, Chen, Fang, Xie, Yi-xiang, Mao, Gao-qin, Liu, Xue-guang, Zhang
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 23(8)
To prepare novel anti-OX40L functional monoclonal antibodies and characterize their distinct biological functions.Routine immunization of BALB/c mice by a tansfected cell line L929/OX40L expressing high level of OX40L as antigens. Then fuse the immun
Autor:
Q. Dai, K.-F. Yang, Qin Wang, Fang-Xie, Yong-jing Chen, Yinghui Zhou, Yan Ge, Zhang Xueyou, Yizhou Hu, Xuefeng Wang, Yi-xiang Mao
Publikováno v:
Tissue antigens. 69(2)
B and T lymphocyte attenuator (BTLA) has been recently identified as a new inhibitory receptor of the CD28 superfamily, with similarities to cytotoxic T lymphocyte activation antigen (CTLA)-4 and programmed death (PD)-1. Engagement of BTLA on T lymph
Autor:
Yong-jing Chen, Qin Shi, Xiaohong Zhang, Hong-ya Wu, Yi-xiang Mao, Yongping Gu, Qin Wang, Xuefeng Wang, Fang Xie, Yan Ge, G. Yu, Yinghui Zhou
Publikováno v:
Tissue antigens. 67(4)
OX40, a membrane-bound molecule of the tumor-necrosis-factor-receptor superfamily, is a critical costimulatory receptor during the immune response. Here, we newly generated two specific mouse antihuman OX40 monoclonal antibodies (mAbs) (2G2 and 1F7),
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 23(11)
Although the roles of CD40 in B cells have been intensively studied, little is known on the function of CD40 in lung cancer cell lines. This study was to investigate biological effects of soluble CD40 ligand (sCD44L) on lung cancer cell line A549 (CD
Publikováno v:
Onkologie. 32:4-4
Background: The prevalence of CD4+CD25+ regulatory T cells (Tregs) and other T-cell subsets in gastrointestinal cancer patients treated with chemotherapy was investigated. Patients and Methods: The frequencies of Tregs and other T-cell subsets in the
Autor:
XIN XIE, MENG-YAO WU, LIU-MEI SHOU, LONG-PEI CHEN, FEI-RAN GONG, KAI CHEN, DAO-MING LI, WEI-MING DUAN, YU-FENG XIE, YI-XIANG MAO, WEI LI, MIN TAO
Publikováno v:
Oncology Letters; 2015, Vol. 9 Issue 2, p837-844, 8p